4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-14-074300
CIK 0001411158operating
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 7:08 PM ET
Size
14.5 KB
Accession
0001209191-14-074300
Insider Transaction Report
Form 4
Maples Kirk R
Senior VP Program Mgt
Transactions
- Sale
Common Stock
2014-12-09$36.52/sh−40,104$1,464,734→ 4,800 total - Exercise/Conversion
Common Stock
2014-12-09$6.92/sh+19,896$137,680→ 24,696 total - Exercise/Conversion
Common Stock
2014-12-09$5.59/sh+40,104$224,181→ 44,904 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-09$6.92/sh−19,896$137,680→ 18,208 totalExercise: $6.92Exp: 2021-03-31→ Common Stock (19,896 underlying) - Exercise/Conversion
Stock Option (right to buy)
2014-12-09$5.59/sh−40,104$224,181→ 14,896 totalExercise: $5.59Exp: 2022-03-13→ Common Stock (40,104 underlying) - Sale
Common Stock
2014-12-09$36.52/sh−19,896$726,670→ 4,800 total
Footnotes (3)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $36.80, inclusive.
- [F2]1/4 of the shares subject to the option shall vest and become exercisable on the 12 month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable on each monthly anniversary thereafter. The Vesting Commencement Date is January 1, 2011.
- [F3]1/4 of the shares subject to the option shall vest and become exercisable on the 12 month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable on each monthly anniversary thereafter. The Vesting Commencment Date is January 1, 2012.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 7:08 PM ET
- Size
- 14.5 KB